Extra Damages Possible In $22M Stent Suit: Fed. Circ.
The Federal Circuit on Monday affirmed a $22 million verdict against Johnson & Johnson subsidiary Cordis Corp. for infringing Spectralytics Inc.'s patent covering a stent-cutting machine, but vacated the denial of...To view the full article, register now.
Already a subscriber? Click here to view full article